Daniel Podolsky - Agilent Technologies Independent Director

A -- USA Stock  

Fiscal Quarter End: January 31, 2020  

  Director
Dr. Daniel K. Podolsky, M.D., is an Independent Director of Agilent Technologies, Inc. Dr. Podolsky has served as President of the University of Texas Southwestern Medical Center, a leading academic medical center, patient care provider and research institution, since September 2008. Previously Dr. Podolsky also served concurrently as Mallinckrodt Professor of Medicine at Harvard Medical School and the Chief of Gastroenterology at Massachusetts General Hospital. From 2005 to 2008, Dr. Podolsky served as Chief Academic Officer and Faculty Dean, Academic Programs of Partners Healthcare System, Inc., a nonprofit health care system committed to patient care, research, teaching and service. Dr. Podolsky holds the Philip OBryan Montgomery, Jr., M.D. Distinguished Presidential Chair in Academic Administration, and the Doris and Bryan Wildenthal Distinguished Chair in Medical Science. He is a member of the National Academy of Medicine of the US National Academy of Sciences, a member of the Board of the Southwestern Medical Foundation and a member of the Scientific Advisory Board of Antibe Therapeutics, Inc., a company focused on the treatment of diseases characterized by inflammation, pain andor vascular dysfunction. Dr. Podolsky is also a member of the National Academies of Sciences Board on Army Science and Technology.
Age: 64  Director Since 2015      
408-345-8886  http://www.agilent.com

Management Efficiency

The company has return on total asset of 0.03 % which means that for every 100 dollars spent on asset it generated profit of $0.03. This is way below average. Similarly, it shows return on equity (ROE) of 0.05 % implying that it made 0.05 on every $100 invested by shareholders.
The company has accumulated 1.8 B in total debt with debt to equity ratio (D/E) of 37.8 implying that the company may be unable to produce cash to meet its debt commitments. Agilent Technologies has Current Ratio of 2.09 implying that it is liquid and has the capability to pay out its interest payments when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Bill ColstonFluidigm Corporation
2019
Steven AltmanDexCom
2013
Kathleen SebeliusExact Sciences Corporation
2019
Richard CollinsDexCom
2017
David ThompsonExact Sciences Corporation
2014
Yalon FarhiDarioHealth Corp
2016
Robert DickeyEMMAUS LIFE SCIENCES INC NEW
2019
Albert ChenGlobal Cord Blood Corporation
N/A
Daniel LevangieExact Sciences Corporation
2010
Ori ZancoDarioHealth Corp
2018
Malcolm HoenleinDarioHealth Corp
2011
Hila KarahDarioHealth Corp
2014
Masaharu OsatoEMMAUS LIFE SCIENCES INC NEW
2019
Carlos PayaFluidigm Corporation
2017
Mark FolettaDexCom
2015
Robert WilliamsLaboratory Corporation Of Ameri
2007
Ken LuGlobal Cord Blood Corporation
2009
Sanders WilliamsLaboratory Corporation Of Ameri
2007
Robin SmithEMMAUS LIFE SCIENCES INC NEW
2019
Pierre JacquetExact Sciences Corporation
2019
Evan JonesFluidigm Corporation
2011

Entity Summary

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company was founded in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in USA and is traded on BATS Exchange. It employs 16300 people.Agilent Technologies (A) is traded on BATS Exchange in USA. It is located in 5301 Stevens Creek Boulevard and employs 16,300 people. Agilent Technologies is listed under Measuring and Control Equipment category by Fama And French industry classification.

Agilent Technologies Leadership Team

Daniel Podolsky, Independent Director
Hans Bishop, Independent Director
George Scangos, Independent Director
Sue Rataj, Independent Director
Jacob Thaysen, Senior Vice President, President, Life Sciences and Applied Markets Group
Samraat Raha, Senior Vice President, President, Diagnostics and Genomics Group
Mark Doak, Senior Vice President, President - Agilent CrossLab Group
Paul Clark, Independent Director
Mala Anand, Independent Director
Robert McMahon, Chief Financial Officer, Senior Vice President
Ankur Dhingra, Investor Relations
Hajime Tada, Interim General Counsel
James Cullen, Independent Non-Executive Chairman of the Board
Michael McMullen, CEO and President Director and Member of Executive Committee
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. Unit
Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controllership
Henrik AncherJensen, Senior Vice President and Presidentident - Order Fulfillment
Dow Wilson, Independent Director
Heidi Kunz, Independent Director
Dominique Grau, Senior Vice President - Human Resources
Heidi Fields, Independent Director
Michael Tang, Senior Vice President General Counsel, Secretary
Alicia Rodriguez, Vice President - Investor Relations
Tadataka Yamada, Independent Director
Didier Hirsch, CFO and Sr. VP
Boon Koh, Independent Chairman of the Board
Robert Herbold, Independent Director

Stock Performance Indicators

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Agilent Technologies Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Agilent Technologies and Global Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
Search macroaxis.com